checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
Published 3 months ago • 64 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
2:00
checkmate 8hw: first-line nivolumab plus ipilimumab in msi-h/dmmr mcrc
-
3:24
checkmate 8hw: nivolumab plus ipilimumab versus chemotherapy for metastatic colorectal cancer
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
2:30
dr andre on the efficacy of nivolumab/ipilimumab in msi-h/dmmr mcrc subgroups
-
3:44
keynote-177 & checkmate 142: checkpoint blockade in msi-h/dmmr crc
-
5:37
nivolumab plus ipilimumab improves on chemo in previously untreated msi-h/dmmr mcrc
-
2:37
moving forward with results from checkmate-142 in msi-h mcrc
-
2:32
dr. overman discusses updated findings of checkmate-142 in patients with msi-h mcrc
-
5:59
nivolumab plus low-dose ipilimumab promising for treatment-naïve msi-high mcrc | heinz-josef lenz
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
4:18
john leighton, md, comments on the outcomes of checkmate 142 in mcrc
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
4:58
long-term results from checkmate 040: nivolumab ipilimumab in advanced hcc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
1:44
checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac